Electrophysiology consumables procurement in Europe: implications for access, innovation and value-based care

EP Europace Journal

10 March 2026
Organised by: Logo
ESC Journals ARRHYTHMIAS AND DEVICE THERAPY Arrhythmias, General Public Health and Health Economics Atrial Fibrillation (AF) Supraventricular Tachycardia (Non-Atrial Fibrillation)

Abstract

AbstractAims

To examine and compare public procurement systems for electrophysiology (EP) consumables across 21 European countries, focusing on governance level, evaluation methods, clinician involvement, reimbursement variability, access to innovation, and sustainability integration.

Methods and results

A qualitative, exploratory design was employed using 22 semi-structured interviews with EP clinicians, procurement specialists, and health system stakeholders across 21 countries. Interview transcripts and summaries were thematically coded by two independent researchers using a structured six-domain framework. Substantial heterogeneity in procurement practices was identified. Hospital-level procurement predominates in 43% of countries, while 33% use regional-level tenders; a minority operate national-level frameworks. Evaluation methods vary, with several countries using price-driven criteria, while others apply mixed or clinically weighted models. Clinician involvement is high or moderate in two-thirds of countries but often informal or lacking governance structure. Reimbursement for EP procedures varies widely in scope and transparency, with bundled and global budget models affecting innovation uptake. Innovation access remains uneven: countries such as Austria, the Netherlands, and France use innovation funds or dedicated pathways, while others rely on centralized approvals or re-tendering. Sustainability criteria are rarely formalized in procurement decisions, despite growing awareness of environmental impact.

Conclusion

European procurement systems for EP consumables differ markedly in structure, evaluation practices, and alignment with clinical and innovation priorities. Integrating clinician input, adopting value-based frameworks, and embedding sustainability metrics could enhance procurement outcomes and patient care. Harmonized guidance from EHRA and EU-level stakeholders may support more equitable and innovation-friendly procurement strategies.

Contributors

Nikola Kozhuharov
Nikola Kozhuharov

Author

Inselspital Bern , Switzerland

Runa Landen
Runa Landen

Author

Institute of Medicine - Sahlgrenska Academy - University of Gothenburg Gothenburg , Sweden

Elena Arbelo
Elena Arbelo

Author

Hospital Clinic, University of Barcelona Barcelona , Spain

Martin Martinek
Martin Martinek

Author

Ordensklinikum Linz Elisabethinen Linz , Austria

Philipp Sommer
Philipp Sommer

Author

Heart and Diabetes Center NRW Bad Oeynhausen , Germany

Michiel Rienstra
Michiel Rienstra

Author

University Medical Centre Groningen Groningen , Netherlands (The)

Michal Farkowski
Michal Farkowski

Author

Ministry of Interior and Administration National Medical Institute Warsaw , Poland

Diana Tint
Diana Tint

Author

Transilvania University of Brasov Brasov , Romania

Stefan Simovic
Stefan Simovic

Author

Faculty of Medical Sciences, University of Kragujevac Kragujevac , Serbia

Krasimir Dzhinsov
Krasimir Dzhinsov

Author

University Hospital Sveti Georgi Sofia , Bulgaria

Giuseppe Boriani
Giuseppe Boriani

Author

Modena Polyclinic Modena University Hospital Modena , Italy

Jose Luis Merino Llorens
Jose Luis Merino Llorens

Author

La Paz University Hospital Madrid , Spain

Haran Burri
Haran Burri

Author

University hospitals of Geneva Geneva , Switzerland

Helmut Pürerfellner
Helmut Pürerfellner

Author

Ordensklinikum Linz Elisabethinen Linz , Austria

ESC 365 is supported by